WO1989007438A1 - Substance active de traitement d'alterations de la peau et des muqueuses - Google Patents

Substance active de traitement d'alterations de la peau et des muqueuses Download PDF

Info

Publication number
WO1989007438A1
WO1989007438A1 PCT/EP1989/000117 EP8900117W WO8907438A1 WO 1989007438 A1 WO1989007438 A1 WO 1989007438A1 EP 8900117 W EP8900117 W EP 8900117W WO 8907438 A1 WO8907438 A1 WO 8907438A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
mixture
skin
salt
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1989/000117
Other languages
German (de)
English (en)
French (fr)
Inventor
Hans-Gerd Kaiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO1989007438A1 publication Critical patent/WO1989007438A1/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the invention is based on the fact that a change in the metabolism occurs as a result in most diseases. With these metabolic changes, differences in the area of trace elements can be found to a considerable extent. It is well known that a lack of trace elements causes specific deficiency symptoms. An oversupply also triggers atypical diseases.
  • EDTA ethylenediaminetetaracetic acid
  • DE-OS 16 17 607 specifies mixtures of heavy metal salts, mono- and polybasic di-nitrilo-R-carboxylic acids and R-oxy-R-carboxylic acids which have physiological effects in rheumatism, viral infections and to promote wound healing.
  • the active substance according to the invention has been used in various changes to the skin and the mucous membrane:
  • Diaonosis acne vulgaris (for 7 years)
  • the mixture of substances was also applied as a gel in order to achieve better adhesion to the areas to be treated.
  • the solution was brought to the consistency of ointments with highly disperse silica.
  • a solution consisting of: 10% by weight potassium citrate
  • a solution consisting of: 20% by weight potassium citrate
  • Diagnosis Wasp sting with local infection, allergic skin reaction and swelling of the left lower leg laterally.
  • test participants diluted the starting solution themselves with tap water to 1: 1 - 1: 4 and garnished 3-4 times a day. After 2 to 3 days, the test subjects were free of symptoms 10. With a solution of: 20% by weight ammonium citrate 10% by weight ethylenedinitrilotetraacetic acid - disodium salt - dihydrate 70% by weight W / 0 emulsion
  • Solution consisting of: 3% by weight ammonium tartrate
  • Solution consisting of: 0.1% by weight of nitrilotriacetic acid, 0.2% by weight of fumaric acid disodium salt
  • Diagnosis contact dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/EP1989/000117 1988-02-11 1989-02-09 Substance active de traitement d'alterations de la peau et des muqueuses Ceased WO1989007438A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19883804141 DE3804141C1 (https=) 1988-02-11 1988-02-11
DEP3804141.3 1988-02-11

Publications (1)

Publication Number Publication Date
WO1989007438A1 true WO1989007438A1 (fr) 1989-08-24

Family

ID=6347128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1989/000117 Ceased WO1989007438A1 (fr) 1988-02-11 1989-02-09 Substance active de traitement d'alterations de la peau et des muqueuses

Country Status (4)

Country Link
EP (1) EP0328091A3 (https=)
AU (1) AU3039789A (https=)
DE (1) DE3804141C1 (https=)
WO (1) WO1989007438A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19620644A1 (de) * 1996-05-22 1997-11-27 Ciba Geigy Ag Verwendung von stickstoffhaltigen Komplexbildnern zur Desodorierung und antimikrobiellen Behandlung der Haut und textilen Fasermaterialien
ES2110921B1 (es) * 1996-08-08 1998-10-01 Ternum S C C L Composicion anti-psoriasica y procedimiento para la preparacion de la misma.
AT407607B (de) * 1996-10-10 2001-05-25 Reinhart Dr Jarisch Verwendung von dtpa zum herstellen einer schutzcreme zur vorbeugung gegen kontaktdermatitiden auf nickel
FR2834635A1 (fr) * 2002-01-17 2003-07-18 Oreal Utilisation de l'acide methyl glycinediacetique ou de ses derives comme desquamant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1861189A (en) * 1929-12-20 1932-05-31 Pfizer Charles & Co Dentifrice
US3452049A (en) * 1965-09-24 1969-06-24 Guardian Chem Corp Mono-magnesium polyamino ethylenediamine tetraacetate:glucono citrate complex
US3558769A (en) * 1965-09-24 1971-01-26 Guardian Chemical Corp Compositions for dental prophylaxis
FR2108827A1 (en) * 1970-10-09 1972-05-26 Ctre Etu Rech Control Sodium gluconate composns - for removing dental tartar
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617607A1 (de) * 1966-01-25 1971-04-01 Erhardt Mayr Verfahren zum Herstellen von physiologisch wirksamen Mischungen
PH13782A (en) * 1976-09-07 1980-09-26 E Scott Therapeutic treatment of dry skin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1861189A (en) * 1929-12-20 1932-05-31 Pfizer Charles & Co Dentifrice
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations
US3452049A (en) * 1965-09-24 1969-06-24 Guardian Chem Corp Mono-magnesium polyamino ethylenediamine tetraacetate:glucono citrate complex
US3558769A (en) * 1965-09-24 1971-01-26 Guardian Chemical Corp Compositions for dental prophylaxis
FR2108827A1 (en) * 1970-10-09 1972-05-26 Ctre Etu Rech Control Sodium gluconate composns - for removing dental tartar

Also Published As

Publication number Publication date
EP0328091A3 (de) 1990-08-16
DE3804141C1 (https=) 1989-07-06
EP0328091A2 (de) 1989-08-16
AU3039789A (en) 1989-09-06

Similar Documents

Publication Publication Date Title
EP0060553B1 (de) Präparat zur Behandlung von Wunden der Hautoberfläche und Verfahren zur Herstellung des Präparats
DE60032543T2 (de) Topisch verabreichbare Zinkzusammensetzungen
EP0217975A1 (de) Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
DE3011182A1 (de) Zur oralen verabreichung geeignete zusammensetzung
DE3033893A1 (de) Therapeutische triaethylentetramin enthaltende zusammensetzung zur lokalen behandlung von hautzustaenden und ihre verwendung
DE69825279T2 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
EP0037488A2 (de) Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen
EP1450825A1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
DE69519040T2 (de) Zusammensetzung zur hygiene,prophylaxe und behandlung der mundhöhle
EP0326145A1 (de) Silbersulfadiazinhaltiges Mittel zur lokalen äusserlichen Therapie
CH645268A5 (de) Bakteriostatikum und verfahren zu dessen herstellung.
DE102015218892A1 (de) Applikationsgemisch zur Erhöhung der Wirkung von Antiseptika und/oder Desinfektionsmitteln, Applikationsmittel mit dem Gehalt des Applikationsgemischs und die Verwendung dieses Gemischs
DE3804141C1 (https=)
EP0366888B1 (de) Pharmazeutische Zubereitung zur Behandlung entzündeter Nasenschleimhäute
DE60011432T2 (de) Kräuterzusammensetzungen für juckreiz oder infizierte hautteile
AT403434B (de) Topische zusammensetzung zur beschleunigung der wundheilung
DE3016359A1 (de) Zahn- bzw. mundwasserloesung zur bildung von schutzfilem und hierfuer geeignetes verfahren
DE10109925B4 (de) Wund- und Schleimhautantiseptikum
DE69709317T2 (de) Antiseptische zusammensetzungen auf basis von chlorobutanol und chlorhexidin
DE2426393C3 (de) Gebrauchsfertiges flüssiges Gurgelmittel mit antimikrobieller Wirksamkeit
DE1492023A1 (de) Hautpflegemittel
WO2000025763A2 (de) Phenolderivaten enthaltendes mittel mit proliferationshemmender wirkung auf tumorzellen
DE2920071A1 (de) Gegen entzuendliche zahnfleischerkrankungen therapeutisch wirkendes mundpflegemittel
DE2727236A1 (de) Verfahren zur herstellung von loesungen filtrierter lysate, wobei von mikroorganismenkulturen ausgegangen wird und danach hergestelltes heilmittel
DE1668563C3 (de) Cer(lll)-L(+)-lactat, Verfahren zu seiner Herstellung und diese enthaltende pharmazeutische Präparate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BR DK FI JP KR LK MC MG MW NO US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG